OMIX

checkpoint inhibitor-related pneumonitis

OMIX004420

1Summary
Title checkpoint inhibitor-related pneumonitis
Description Immune checkpoint inhibitors (ICIs) therapy induced pneumonitis (CIP) complicates this effective therapy in patients with non-small cell lung cancer (NSCLC) and makes it difficult to classify from other pneumonitis. Comprehensively dissecting the key cellular players and molecular pathways associated with CIP pathobiology is critical for precision diagnosis and develop novel therapy strategy of CIP. Here, we implemented comprehensive single-cell transcriptome, flow cytometry and cytokine expression analysis to shed light on the complexity of the immunological responses in the bronchoalveolar microenvironment from NSCLC patients with CIP.
Organism Homo sapiens
Data Type Expression Profiling by NGS
Data Accessibility Controlled-access
BioProject PRJCA008590
Release Date 2023-06-26
Submitter Yi Hu (huyi_0912@126.com)
Organization the Fifth Medical Center of PLA General Hospital
Submission Date 2023-06-26
2Files & Download

The data cannot be downloaded as it has not yet been registered in the Human Genetic Resource Management Platform of MOST.

File ID File Title Number/Samples File Type File Size File Suffix Download Times Download
OMIX004420-01 BP7 1 Expression Profiling by NGS 22.39 MB tar 0 Unavailable
OMIX004420-02 BC6 1 Expression Profiling by NGS 13.74 MB tar 0 Unavailable
OMIX004420-03 BC4 1 Expression Profiling by NGS 23.72 MB tar 0 Unavailable
OMIX004420-04 BC5 1 Expression Profiling by NGS 16.48 MB tar 0 Unavailable

Request for this Data View All Released Data of OMIX